Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy

JMA Journal 2026 Open access

Read full text
Authors: Akinori Minato, Yoshihiro Sugita, Yui Mizushima, Shuki Watanabe, Takuo Matsukawa, Kazumasa Jojima, Rieko Kimuro, Katsuyoshi Higashijima, Yujiro Nagata, Ikko Tomisaki, Eiji Kashiwagi
DOI: 10.31662/jmaj.2025-0463
Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Urinary Tract Infections Management

Publication details

Journal / source
JMA Journal
Volume
9
Issue
2
Pages
1001–1005
Publication date
1 January 2026
Language
EN